Actively Recruiting
Vulvar Disease in Nigeria Registry Observational Study
Led by KDRS ltd · Updated on 2023-06-06
1000
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study focuses on vulvar diseases, including vulvar atrophy and dermatoses, within communities in Nigeria. The research aims to assess awareness of these conditions among patients and healthcare practitioners, as well as to determine both self-reported and actual prevalence rates in the population. The sponsor for this study is KDRS ltd. Participants in this study will be observed without receiving any active treatment as the study involves gathering information on the prevalence of vulvar diseases. The study does not include any intervention or medication but relies on observation and data collection over the course of the study period. During their participation, individuals will be monitored for the presence of vulvar diseases through self-reporting and possibly clinical observation. The primary outcome measured is the prevalence of vulvar disease within 1 to 12 months. The study is designed for female participants aged 10 to 90 years and will continue until November 30, 2026.
CONDITIONS
Brief Title
Vulvar Disease in Nigeria Observational Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biological females (assigned female at birth)
You will not qualify if you...
- Not biologically female (not assigned female at birth) participants are excluded from the study
- None else specified in exclusion criteria provided by the study data (only non-biological females are excluded). This line is added to clarify but is not strictly from source. If strict source adherence is required, only the first bullet is included and this is omitted.
Note: The source states only "none-afab" as exclusion, so only the first bullet is included here for strict adherence.
- Not biologically female (not assigned female at birth)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 to 12 months
Participants are observed to assess the prevalence of vulvar disease over time.
1 to 2 visits depending on participant availability
Trial Site Locations
Total: 1 location
1
Kdrs
London, United Kingdom, Rm166el
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here